These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21738133)

  • 1. Trial puts niacin--and cholesterol dogma--in the line of fire.
    Dolgin E
    Nat Med; 2011 Jul; 17(7):756. PubMed ID: 21738133
    [No Abstract]   [Full Text] [Related]  

  • 2. Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients.
    Masana L; Cabré A; Heras M; Amigó N; Correig X; Martínez-Hervás S; Real JT; Ascaso JF; Quesada H; Julve J; Palomer X; Vázquez-Carrera M; Girona J; Plana N; Blanco-Vaca F
    Atherosclerosis; 2015 Feb; 238(2):213-9. PubMed ID: 25528430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niacin, fenofibrates increase benefits for statin users. These HDL- raising, triglyceride-lowering drugs beat out the use of additional LDL-lowering drugs.
    Duke Med Health News; 2010 Aug; 16(8):1-2. PubMed ID: 20799416
    [No Abstract]   [Full Text] [Related]  

  • 4. Paradoxical decrease in serum high-density lipoprotein cholesterol with Tredaptive® (m/r nicotinic acid 1 g and laropiprant 20 mg).
    Sharpe P
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):584-5. PubMed ID: 21868415
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niacin after coronary bypass grafting and for coronary disease prevention.
    Parsons WB
    Circulation; 2001 Jul; 104(2):E7. PubMed ID: 11447097
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome.
    Gomaraschi M; Ossoli A; Adorni MP; Damonte E; Niesor E; Veglia F; Franceschini G; Benghozi R; Calabresi L
    Vascul Pharmacol; 2015 Nov; 74():80-86. PubMed ID: 26133666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niacin: its value in raising HDL cholesterol is being questioned.
    Heart Advis; 2011 Oct; 14(10):7. PubMed ID: 23019714
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination lipid therapy in type 2 diabetes.
    Sacks FM; Carey VJ; Fruchart JC
    N Engl J Med; 2010 Aug; 363(7):692-4; author reply 694-5. PubMed ID: 20842772
    [No Abstract]   [Full Text] [Related]  

  • 10. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
    Brown BG; Zhao XQ; Chait A; Fisher LD; Cheung MC; Morse JS; Dowdy AA; Marino EK; Bolson EL; Alaupovic P; Frohlich J; Albers JJ
    N Engl J Med; 2001 Nov; 345(22):1583-92. PubMed ID: 11757504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg.
    Wi J; Kim JY; Park S; Kang SM; Jang Y; Chung N; Shim WH; Cho SY; Lee SH
    Atherosclerosis; 2010 Nov; 213(1):235-40. PubMed ID: 20855072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoid no-flush niacin in favor of the prescription version. Follow certain steps to reduce the flushing effects of prescription niacin.
    Heart Advis; 2010 Nov; 13(11):5. PubMed ID: 22834056
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol.
    Bowen PH; Guyton JR
    Curr Atheroscler Rep; 2000 Jan; 2(1):58-63. PubMed ID: 11122725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid disorders.
    Kole LA
    JAAPA; 2009 Nov; 22(11):54-5. PubMed ID: 19999177
    [No Abstract]   [Full Text] [Related]  

  • 15. Raising high-density lipoprotein cholesterol with niacin and fibrates: a comparative review.
    Sprecher DL
    Am J Cardiol; 2000 Dec; 86(12A):46L-50L. PubMed ID: 11374856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin into the void. Failure of HDL cholesterol drug may B this vitamin's big chance.
    Harv Health Lett; 2007 Apr; 32(6):6. PubMed ID: 17390509
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing high-density lipoprotein cholesterol: an update on fenofibrate.
    Després JP
    Am J Cardiol; 2001 Dec; 88(12A):30N-36N. PubMed ID: 11788128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of simvastatin-niacin and antioxidant therapy on HDL.
    Drown DJ
    Prog Cardiovasc Nurs; 2002; 17(2):102-3. PubMed ID: 11986546
    [No Abstract]   [Full Text] [Related]  

  • 19. [Niacin--an additive therapeutic approach for optimizing lipid profile].
    Wieneke H; Schmermund A; Erbel R
    Med Klin (Munich); 2005 Apr; 100(4):186-92. PubMed ID: 15834527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.